Aytu Biopharma AYTU
NASDAQ AYTU
$2.14 -0.06 (-2.73%)
As of: Sep 30, 2026 · 3:59 PM EDT

Aytu Biopharma (AYTU) Deferred Taxes (2014)

Updated

Aytu Biopharma (AYTU) reported Deferred Taxes of -$23,910 for FY2015 (year ended Jun 30, 2015), compared with -$813,697 in FY2014.

Analysis

Aytu Biopharma (AYTU) Deferred Taxes (2014) Analysis & Trends

  • According to Business Quant data, Deferred Taxes came in at -$813,697 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -479.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -195.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Aytu Biopharma 23.91 Mn -91.77 Mn 10.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -1.00
Sep 30, 2014 -23,909.00
API Access

Aytu Biopharma Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=AYTU&period=max&api_key=YOUR_API_KEY